The recent advances in genomics and molecular genetics have expanded our understanding of the etiology and pathogenesis of cancer. The Training Program in the Molecular Genetics of Cancer at The Kimmel Cancer Center was established to keep pace with the rapid progress in the understanding of our genome. The KCC offers training in the Molecular Genetics of Cancer leading to a Ph.D. degree in Genetics. Research training primarily by the student's Mentor with the active participation of the Research Advisory Committee, and supplemented by coursework, seminars and symposia, integrates a diverse blend of research faculty involved in various disciplines focused on cancer research. The goal of the program is to provide aspiring researchers with the training and experience necessary for them to establish successful careers as independent investigators in cancer and cancer-related careers. Predoctoral trainees complete a rigorous series of graduate courses giving them a thorough background in genetics, genomics, cancer biology, bioinformatics, oncology, and molecular biology. Formal curriculum emphasizes the basic sciences of genetics, molecular genetics, biochemistry and cell biology followed by more specialized advanced courses. Students also have ample opportunity to present seminars, based on their own work as well as those in the current literature, to faculty and fellow students. In order for the students to sample the different research topics and laboratory environments available, the students are required to complete at least three laboratory rotations within the first year of matriculation. The Ph.D. program is available to students who hold a bachelor degree or a master degree from an accredited institution who wish to enter biomedical research as well as individuals holding more advanced degrees who wish academic careers as independent scientific investigators. Applicants must have a solid background in biological and chemical sciences. Previous research experience is desirable. Grade point average, GRE scores, letters of recommendations and an interview are all important criteria that are carefully evaluated for acceptance into the program. Postdoctoral applicants must hold a Ph.D., M.D., or equivalent doctoral degree and acceptance depends upon past research and educational experience. The goal of this program is to develop highly trained, technically competent research scientists capable of performing and eventually direct research involved in furthering the frontiers of the molecular and genetic basis of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009678-15
Application #
7423946
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1992-04-01
Project End
2010-05-31
Budget Start
2008-06-01
Budget End
2010-05-31
Support Year
15
Fiscal Year
2008
Total Cost
$340,154
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Li, Taosui; Hodgson, Jacob W; Petruk, Svetlana et al. (2017) Additional sex combs interacts with enhancer of zeste and trithorax and modulates levels of trimethylation on histone H3K4 and H3K27 during transcription of hsp70. Epigenetics Chromatin 10:43
Trimmer, Casey; Bonuccelli, Gloria; Katiyar, Sanjay et al. (2013) Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation. Am J Pathol 182:992-1004
Capozza, Franco; Trimmer, Casey; Castello-Cros, Remedios et al. (2012) Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration. Cancer Res 72:2262-74
Katiyar, Pragati; Aplin, Andrew E (2011) FOXD3 regulates migration properties and Rnd3 expression in melanoma cells. Mol Cancer Res 9:545-52
Crist, Richard C; Roth, Jacquelyn J; Waldman, Scott A et al. (2011) A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. PLoS One 6:e23665
Crist, Richard C; Roth, Jacquelyn J; Lisanti, Michael P et al. (2011) Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis. Cell Cycle 10:1092-9
Tran, Thai Hong; Lin, Justin; Sjolund, Ashley Brooke et al. (2010) Protocol for constructing tissue arrays by cutting edge matrix assembly. Methods Mol Biol 664:45-52
Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong et al. (2010) Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem 285:9792-802
Liu, Hsing-Yin; Lee, Nancy; Tsai, Tsen-Yi et al. (2010) Zebrafish fat-free, a novel Arf effector, regulates phospholipase D to mediate lipid and glucose metabolism. Biochim Biophys Acta 1801:1330-40
Crist, Richard C; Roth, Jacquelyn J; Baran, Amy A et al. (2010) The armadillo repeat domain of Apc suppresses intestinal tumorigenesis. Mamm Genome 21:450-7

Showing the most recent 10 out of 73 publications